| Lunai Bioworks Inc. |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | | 2015-Mar-31 | 2014-Dec-31 | | | | 2013-Dec-31 |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | | Q1-FY2015 | Q4-FY2014 | | | | Q3-FY2014 |
| Operating Cash Flow | | | (1,811,136$) | (1,487,459$) | (2,559,724$) | (2,016,328$) | (2,413,781$) | (2,633,819$) | (3,146,623$) | (2,777,207$) | (2,261,612$) | (3,307,792$) | (3,384,846$) | (2,653,674$) | (3,050,487$) | (2,784,698$) | (4,620,464$) | (5,276,687$) | (13,028,047$) | (2,330,848$) | (2,496,163$) | (2,755,665$) | (2,245,097$) | (3,838,464$) | (2,575,274$) | (1,800,587$) | (2,218,576$) | (2,737,851$) | (1,754,190$) | (1,796,724$) | (1,611,525$) | (1,732,169$) | | (506,921$) | (498,970$) | (27,669$) | (324,343$) | (326,496$) | (310,267$) | (79,151$) | (666,835$) | (416,036$) | | (2,043,787$) | (2,000,602$) | | | | (16,847$) |
| Investing Cash Flow | | | 964,389$ | | | | (53,373$) | (91,597$) | (57,334$) | (1,057,875$) | (6,141$) | 0$ | | | 0$ | 0$ | 0$ | (5,156$) | (38,171$) | 0$ | | | (10,448$) | (41,694$) | (63,705$) | (68,616$) | 16,507$ | (92,632$) | (332,358$) | (308,186$) | (297,000$) | 4,783,833$ | | (226,200$) | | | | | 0$ | 0$ | 0$ | 1,052,989$ | | 2,029,502$ | (1,965,253$) | | | | |
| Financing Cash Flow | | | 178,357$ | 3,584,253$ | 2,590,979$ | 2,029,183$ | 2,466,718$ | 2,641,055$ | 2,846,865$ | 2,562,817$ | 1,248,048$ | 2,108,633$ | (466,625$) | 1,458,375$ | 1,070,190$ | 229,533$ | | | 29,202,954$ | 3,439,007$ | | | 0$ | 6,200,000$ | 0$ | 1,000,000$ | 4,320,000$ | 0$ | | | 0$ | 11,900,275$ | | (4,499$) | 5,092,931$ | 52,770$ | 0$ | 360,900$ | | | | | | | 6,656,175$ | | | | 3,650$ |
| End Cash Position | | | 92,700$ | 923,002$ | 311,764$ | 220,571$ | 220,467$ | 312,697$ | 243,980$ | 523,474$ | 1,874,480$ | 2,948,042$ | 4,118,896$ | 7,971,918$ | 9,172,142$ | 11,150,917$ | 13,707,907$ | 15,377,050$ | 20,664,410$ | 4,526,284$ | 3,425,050$ | 5,695,661$ | 8,696,361$ | 10,939,166$ | 8,626,677$ | 11,138,252$ | 12,282,224$ | 10,272,198$ | 13,240,240$ | 13,405,185$ | 15,600,865$ | 17,018,493$ | 2,306,129$ | 2,944,659$ | 3,941,712$ | 33,699$ | 117,605$ | 31,675$ | 23,368$ | 151,222$ | 531,260$ | 421,145$ | 421,145$ | 3,434,935$ | 3,008,831$ | | | | 18,794$ |
| Exchange Rate Effect | | | (161,912$) | (21,167$) | 59,938$ | (12,751$) | (91,794$) | 153,078$ | 77,598$ | (78,741$) | (53,857$) | 28,305$ | 22,082$ | (4,925$) | 1,522$ | (1,825$) | 580$ | (5,517$) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dividends Paid | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |